Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$129,531,696
+$5,583,661 QoQ
Shares Held
683,112
+8.7% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#113
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Man Group plc holds $1,927,079,072 across 11 Drug Manufacturers - General names. AZN ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
398,861 | $478,405,888 | |
| 2 | ABBV |
AbbVie Inc.
|
1,704,016 | $428,798,585 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,682,000 | $269,776,838 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,235,196 | $156,054,661 | |
| 5 | JNJ |
Johnson & Johnson
|
517,830 | $131,513,284 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
683,112 | $129,531,696 | |
| 7 | MRK |
Merck & Co., Inc.
|
990,469 | $127,275,266 | |
| 8 | AMGN |
Amgen Inc
|
234,023 | $84,744,407 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $129,531,696 | 683,112 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $123,948,035 | 628,476 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||